Silo Pharma, Inc. Common Stock
$1.84
Market Cap
$3.02M
Shares Outstanding
1.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 5, 2012
Round Lot
100
Locale
US
Day Open
$1.70
Day High
$1.90
Day Low
$1.66
Volume
287.5K
VWAP
$1.76
Prev Close
$1.72
Transactions
--
Acc. Volume
--
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Silo Pharma, Inc. Common Stock (SILO) closed the 2026-09-18 session at $1.84, up 6.98% versus the previous close (+0.12). The stock opened at $1.70 and traded between $1.66 and $1.90 during that session. Session trading volume was 288K shares. The volume-weighted average price (VWAP) is $1.76.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Silo Pharma, Inc. Common Stock has a market capitalization of $3.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SILO is listed on the XNAS exchange. The company employs approximately 3 people. Silo Pharma, Inc. Common Stock is headquartered in SARASOTA, FL. The recorded listing date is 2012-01-05.
On this page you can find market SILO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.